Barr Pharmaceuticals, Inc. (NYSE:BRL.DL)

CAPS Rating: No stars

A specialty pharmaceutical Company, which is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals.

Featured Broker Partners


Advertisement